March 29, 2024 00:58 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi has mastered art of manipulating democracy, hurting Constitution: Mallikarjun Kharge | Mafia-turned-politician Mukhtar Ansari dies of cardiac arrest at 63 | NIA arrests key conspirator in Bengaluru cafe blast case | Actor Govinda returns to politics after 14 years of 'vanvas', joins Eknath Shinde camp | 'To browbeat and bully others is vintage Congress culture': PM posts after 600 lawyers write to CJI
Decision on Covaxin's clearance next: WHO WHO | Covaxin
Image Credit and Caption: Image tweeted by @IndianEmbassyTR

Decision on Covaxin's clearance next: WHO

India Blooms News Service | @indiablooms | 05 Oct 2021, 10:50 pm

New Delhi/IBNS: The World Health Organisation (WHO) on Tuesday said it will announce its decision on clearance of India's indigenously developed Covaxin next week when the UN agency and an independent group of experts meet.

This comes almost a week after WHO delayed the emergency use authorisation (EUA) for Covaxin as the global body sent more technical queries to its manufacturer- pharmaceutical major Bharat Biotech.

"WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin," WHO tweeted on Tuesday evening.

Bharat Biotech "has been submitting data to the WHO on a rolling basis and submitted additional info at WHO's request on 27 September", another tweet read.

"WHO experts are currently reviewing this info and if it addresses all questions raised, the WHO assessment will be finalised next week."

Without an EUA, Covaxin will not be considered an accepted vaccine by most countries to allow entry to such vaccinated students.

Serum Institute's Covishield is the only Indian-made vaccine to find a place in the list of approved ones globally for now.

India is also among the 33 countries from where fully vaccinated travellers will be allowed to enter the United States from November.

So far, only seven vaccines have been approved for use by the WHO including Moderna, Pfizer-BioNTech, Johnson & Johnson, Oxford-AstraZeneca, Covishield (an Oxford-AstraZeneca formulation) and China's Sinopharm and Sinovac.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.